Deborah Marriott - Concepedia

Author

Deborah Marriott

Also Known As

D J E Marriott, D J Marriott, D Marriott, D. J. E. Marriott, D. J. Marriott, D. MARRIOTT, D. Marriott, D.J. Marriott, D.J.E. Marriott, DEBORAH MARRIOTT

180

Publications

9.8K

Citations

H-Index

121

Concepts

All Affiliations

St Vincent's Hospital Sydney St Vincent's Hospital Melbourne Westmead Hospital The University of Sydney UNSW Sydney

About

Deborah Marriott is an author at St Vincent's Hospital Sydney specializing in medicine, microbiology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	53	3K
2	Health Sciences	4	4	296
3	Natural Sciences	2	2	90
4	Engineering	1	1	25
5	Nursing	1	1	10

Deborah Marriott

107

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New Zealand Tania C. Sorrell, Graeme R. Nimmo, Bryan Speed, Clinical Infectious Diseases	2000	462
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy Andrew Carr, Deborah Marriott, Andrew Field, The Lancet Combination Antiretroviral TherapyImmunologyMicrobiologyHivMedicine	1998	342
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS Andrew Carr, Brett Tindall, Bruce J. Brew, Annals of Internal Medicine	1992	236
Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients Christopher C. Blyth, Monica A. Slavin, Carolina Serena, PEDIATRICS	2009	206
Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death Sharon C.-A. Chen, Monica A. Slavin, Christopher H. Heath, Clinical Infectious Diseases	2012	199
Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality Monica A. Slavin, Sebastiaan J. van Hal, Tania C. Sorrell, Clinical Microbiology and Infection Pathogenic MicrobiologyFilamentous FungiFungal PathogenClinical MycologyFungal Biology	2015	179
Active Surveillance of Candidemia, Australia Sharon Chen, Monica A. Slavin, Quoc Nguyen, Emerging infectious diseases Diagnostic MycologyPathogenic MicrobiologyClinical MycologyHospital MedicineHealthcare-associated Infection	2006	174
Voriconazole concentrations and outcome of invasive fungal infections Spiros Miyakis, Sebastiaan J. van Hal, John E. Ray, Clinical Microbiology and Infection Antifungal AgentAntifungal AgentsMedicineMicrobiologyInvasive Fungal Infections	2009	157
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. E Geoffrey Playford, Deborah Marriott, Quoc Nguyen, Critical Care Medicine	2008	156
Evaluation of Multiplex Tandem Real-Time PCR for Detection of <i>Cryptosporidium</i> spp., <i>Dientamoeba fragilis</i> , <i>Entamoeba histolytica</i> , and <i>Giardia intestinalis</i> in Clinical Stool Samples Damien Stark, Sarwat Al-Qassab, Joel Barratt, Journal of Clinical Microbiology Parasitic DiseasePathogen DetectionGastroenterologyPathologyProtozoan Species	2010	136

Page 1